GENEVA, Oct. 1 -- HIGENE (HANGZHOU) BIOTECHNOLOGY CO., LTD. filed a patent application (CN2025/081667) for “USE OF PHARMACEUTICAL COMPOSITION IN PREPARATION OF FORMULATION FOR TREATING PARKINSON'S SYNDROME”. With publication no. WO/2026/188369, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 38/17

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....